Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Cash from Financing Activities (2019 - 2025)

AVITA Medical filings provide 7 years of Cash from Financing Activities readings, the most recent being $248000.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 75.71% to $248000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $14.9 million, a 325.77% increase, with the full-year FY2025 number at $14.9 million, up 325.77% from a year prior.
  • Cash from Financing Activities hit $248000.0 in Q4 2025 for AVITA Medical, down from $13.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $64.0 million in Q1 2021 to a low of -$64.0 million in Q2 2022.
  • Median Cash from Financing Activities over the past 5 years was $579500.0 (2023), compared with a mean of $2.6 million.
  • Biggest five-year swings in Cash from Financing Activities: soared 98404.62% in 2021 and later tumbled 397.95% in 2022.
  • AVITA Medical's Cash from Financing Activities stood at $3000.0 in 2021, then skyrocketed by 29866.67% to $899000.0 in 2022, then soared by 4286.21% to $39.4 million in 2023, then plummeted by 97.41% to $1.0 million in 2024, then plummeted by 75.71% to $248000.0 in 2025.
  • The last three reported values for Cash from Financing Activities were $248000.0 (Q4 2025), $13.8 million (Q3 2025), and $559000.0 (Q2 2025) per Business Quant data.